Yuen MF, Lai CL.
Prevention and management of drug resistance for antihepatitis
B treatment. Lancet Infect Dis 2009;9(4):256-64.
Lai CL , Yuen
MF. Chronic hepatitis B – new goals, new treatment.
N Engl J Med 2008;359(23):2488-91.
Yuen MF, Wong
DKH, Fung J, Ip P, But D, Hung I, Lau K, Yuen JCH, Lai CL.
HBsAg seroclearance in chronic hepatitis B in Asian patients:
Replicative level and risk of hepatocellular carcinoma.
Gastroenterology 2008;135(4):1192-1199.
Yuen MF, Fong
DYT, Wong DKH, Yuen JCH, Fung J, Lai CL. HBV DNA levels
at week 4 of lamivudine treatment predict 5-year “ideal
response” Hepatology 2007;46(6):1695-1703.
Lai CL, Yuen MF.
The natural history and treatment of CHB: critical evaluation
of treatment criteria and endpoints. Ann Intern Med 2007;147(1):58-61.
Yuen MF, Lai CL.
Treatment for chronic hepatitis B. The Lancet Infect
Dis 2001; 1(4): 232 – 241.
Key
Offices
Chief, Division of Gastroenterology & Hepatology, The University of Hong Kong,
Queen Mary Hospital, Hong Kong
President, Hong
Kong Association for the Study of Liver Diseases
Assistant Dean,
Li Ka Shing Faculty of Medicine, The University of Hong Kong,
Queen Mary Hospital, Hong Kong
Deputy Chairman,
Institutional Review Board of the University of Hong Kong/
Hospital Authority, Hong Kong West Cluster
Member, Supplementary
Medical Professions Council, Food and Health Bureau, Government
Secretariat, The Government of the Hong Kong Special Administrative
Region, The People’s Republic of China
Prof
YUEN Man Fung - Li Shu Fan Medical Foundation Professorship in Medicine